DRUG NAME
DOSAGE & ROUTE
MECHANISM OF ACTION
INDICATION
CONTRAINDICATION
SIDE EFFECTS/ ADVERSE REACTIONS
NURSING RESPONSIBILITY
Ketorolac
30mg/amp1 amp IM
Toradol CLASSIFICATI ON: Nonsteroidal antiinflammatory agents, nonopioid analagesics
Inhibits prostaglandin synthesis, producing peripherally mediated analgesia - Also has antipyretic and antiinflammatory properties. - Therapeutic effect:Decreased pain
Short term management of pain (not to exceed 5 days total for all routes combined
DRUG NAME
DOSAGE & ROUTE
MECHANISM OF ACTION
INDICATION
CONTRAINDICATION
SIDE EFFECTS/ ADVERSE REACTIONS
NURSING RESPONSIBILITY
Ketorolac
30mg/amp1 amp IM
Toradol CLASSIFICATI ON: Nonsteroidal antiinflammatory agents, nonopioid analagesics
Inhibits prostaglandin synthesis, producing peripherally mediated analgesia - Also has antipyretic and antiinflammatory properties. - Therapeutic effect:Decreased pain
Short term management of pain (not to exceed 5 days total for all routes combined
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOCX, PDF, TXT or read online from Scribd
DRUG NAME
DOSAGE & ROUTE
MECHANISM OF ACTION
INDICATION
CONTRAINDICATION
SIDE EFFECTS/ ADVERSE REACTIONS
NURSING RESPONSIBILITY
Ketorolac
30mg/amp1 amp IM
Toradol CLASSIFICATI ON: Nonsteroidal antiinflammatory agents, nonopioid analagesics
Inhibits prostaglandin synthesis, producing peripherally mediated analgesia - Also has antipyretic and antiinflammatory properties. - Therapeutic effect:Decreased pain
Short term management of pain (not to exceed 5 days total for all routes combined
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOCX, PDF, TXT or read online from Scribd
DRUG NAME DOSAGE & MECHANISM OF ACTION INDICATION CONTRAINDICATION SIDE EFFECTS/ NURSING RESPONSIBILITY
ROUTE ADVERSE REACTIONS
30mg/amp1 Inhibits Hypersensitivity CNS:drowsiness Patients who have asthma, prostaglandin Short term - Cross-sensitivity abnormal thinking, aspirin-induced allergy, and Ketorolac amp IM management of synthesis, producing with other NSAIDs dizziness, euphoria, nasal polyps are at increased peripherally pain (not to may exist¨Pre- or headache- risk for developing mediated analgesia exceed 5 days perioperative use - RESP:asthma hypersensitivity reactions. Toradol - Also has total for all - Known alcohol ,dyspnea Assess for rhinitis, asthma, and antipyretic and anti- routes intoleranceUse - CV: urticaria. inflammatory combined) cautiously in: edema - Assess pain (note type, CLASSIFICATI properties. 1) History of GI pallor location, and intensity) prior to ON: - Therapeutic bleeding vasodilation and 1-2 hr following Nonsteroidal anti- effect:Decreased 2) Renal impair- - GI: administration. inflammatory pain ment (dosage 1) GI Bleeding - Ketorolac therapy should agents, nonopioid reduction may be 2) abnormal taste always be given initially by the analagesics required) 3) diarrhea IM or IV route. Oral therapy 3) Cardiovascular 4) dry mouth should be used only as a disease 5) dyspepsia continuation of parenteral 6) GI pain therapy. 7) nausea - Caution patient to avoid GU: concurrent use of alcohol, 1) oliguria aspirin, NSAIDs, 2) renal toxicity acetaminophen, or other OTC 3) urinary medications without consulting frequency health care professional. - DERM: - Advise patient to consult if 1) pruritis rash, itching, visual 2) purpura disturbances, tinnitus, weight 3) sweating gain, edema, black stools, 4) urticaria persistent headche, or - HEMAT: influenza-like syndromes 1) prolonged (chills,fever,muscles aches, bleeding time pain) occur. - LOCAL: - Effectiveness of therapy can 1) injection site be demonstrated by decrease pain in severity of pain. Patients - NEURO: who do not respond to one 1) paresthesia NSAIDs may respond to - MISC: another. 1) allergic reaction, anaphylaxis